ArticleJournal of experimental & clinical cancer research : CR2018

Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.

Francesco Marchesi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.